. 2019 Jan; 321(3):288-300.
doi: 10.1001/jama.2018.19323.

Breast Cancer Treatment: A Review

Adrienne G Waks 1 Eric P Winer 1 
  • PMID: 30667505
  •     445 citations


Importance: Breast cancer will be diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and evolving strategies for local and systemic therapy of breast cancer.

Observations: Breast cancer is categorized into 3 major subtypes based on the presence or absence of molecular markers for estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; formerly HER2): hormone receptor positive/ERBB2 negative (70% of patients), ERBB2 positive (15%-20%), and triple-negative (tumors lacking all 3 standard molecular markers; 15%). More than 90% of breast cancers are not metastatic at the time of diagnosis. For people presenting without metastatic disease, therapeutic goals are tumor eradication and preventing recurrence. Triple-negative breast cancer is more likely to recur than the other 2 subtypes, with 85% 5-year breast cancer-specific survival for stage I triple-negative tumors vs 94% to 99% for hormone receptor positive and ERBB2 positive. Systemic therapy for nonmetastatic breast cancer is determined by subtype: patients with hormone receptor-positive tumors receive endocrine therapy, and a minority receive chemotherapy as well; patients with ERBB2-positive tumors receive ERBB2-targeted antibody or small-molecule inhibitor therapy combined with chemotherapy; and patients with triple-negative tumors receive chemotherapy alone. Local therapy for all patients with nonmetastatic breast cancer consists of surgical resection, with consideration of postoperative radiation if lumpectomy is performed. Increasingly, some systemic therapy is delivered before surgery. Tailoring postoperative treatment based on preoperative treatment response is under investigation. Metastatic breast cancer is treated according to subtype, with goals of prolonging life and palliating symptoms. Median overall survival for metastatic triple-negative breast cancer is approximately 1 year vs approximately 5 years for the other 2 subtypes.

Conclusions And Relevance: Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct risk profiles and treatment strategies. Optimal therapy for each patient depends on tumor subtype, anatomic cancer stage, and patient preferences.

PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression.
Xiaoli Chen, Yang Lv, +12 authors, Paul Yao.
Front Oncol, 2019 May 07; 9. PMID: 31058090    Free PMC article.
The Inhibitory Effect of Cordycepin on the Proliferation of MCF-7 Breast Cancer Cells, and its Mechanism: An Investigation Using Network Pharmacology-Based Analysis.
Dahae Lee, Won-Yung Lee, +6 authors, Ki Sung Kang.
Biomolecules, 2019 Aug 29; 9(9). PMID: 31454995    Free PMC article.
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4.
Rossella Lucà, Giorgia di Blasio, +16 authors, Fabiola Moretti.
Cancers (Basel), 2019 Sep 25; 11(9). PMID: 31547268    Free PMC article.
DHPS-dependent hypusination of eIF5A1/2 is necessary for TGFβ/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53.
R Güth, Y Adamian, +8 authors, J A Kelber.
Biochem Biophys Res Commun, 2019 Sep 29; 519(4). PMID: 31558321    Free PMC article.
Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.
Marie Joelle Jabagi, Anthony Goncalves, +3 authors, Rosemary Dray-Spira.
Cancers (Basel), 2019 Oct 02; 11(10). PMID: 31569513    Free PMC article.
lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network.
Zijian Liu, Mi Mi, +3 authors, Liling Zhang.
Front Genet, 2019 Oct 02; 10. PMID: 31572452    Free PMC article.
RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery.
Dan Wu, Harrison C Daly, +5 authors, Donal F O'Shea.
Chem Sci, 2019 Oct 08; 10(29). PMID: 31588261    Free PMC article.
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
Mohammad Mijanur Rahman, Andrew C Brane, Trygve O Tollefsbol.
Cells, 2019 Oct 11; 8(10). PMID: 31597272    Free PMC article.
PROTAC-Mediated Degradation of Estrogen Receptor in the Treatment of Cancer.
Robert B Kargbo.
ACS Med Chem Lett, 2019 Oct 18; 10(10). PMID: 31620216    Free PMC article.
LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Kun Qiao, Shipeng Ning, +5 authors, Da Pang.
J Exp Clin Cancer Res, 2019 Oct 19; 38(1). PMID: 31623640    Free PMC article.
MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis.
Giulia Cosentino, Ilaria Plantamura, Alessandra Cataldo, Marilena V Iorio.
Int J Mol Sci, 2019 Oct 20; 20(20). PMID: 31627322    Free PMC article.
Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): systematic scoping review.
Almir G V Bitencourt, Johanna Goldberg, Katja Pinker, Sunitha B Thakur.
Metabolomics, 2019 Nov 07; 15(11). PMID: 31696341
Systematic Review.
High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker.
Konstantinos S Papadakos, Amélie Darlix, William Jacot, Anna M Blom.
Front Oncol, 2019 Nov 19; 9. PMID: 31737569    Free PMC article.
Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase-estrogen receptor axis.
Xing Huang.
Clin Transl Med, 2019 Nov 20; 8(1). PMID: 31741086    Free PMC article.
Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China.
Yuqin Ding, Kaijing Ding, +6 authors, Xiaowen Ding.
Oncol Lett, 2019 Dec 07; 18(6). PMID: 31807179    Free PMC article.
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
Simona Punzi, Chiara Balestrieri, +12 authors, Luisa Lanfrancone.
Breast Cancer Res, 2019 Nov 23; 21(1). PMID: 31752957    Free PMC article.
Past, Present and Future of Flow Cytometry in Breast Cancer - A Systematic Review.
Maria Andreou, Evrysthenis Vartholomatos, +2 authors, George A Alexiou.
EJIFCC, 2019 Dec 10; 30(4). PMID: 31814815    Free PMC article.
A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.
Shuncong Wang, Yewei Liu, +4 authors, Yicheng Ni.
Cancers (Basel), 2019 Nov 27; 11(11). PMID: 31766180    Free PMC article.
Subtype specific targeting of calcium signaling in breast cancer.
Monish Ram Makena, Rajini Rao.
Cell Calcium, 2019 Nov 30; 85. PMID: 31783287    Free PMC article.
Phenotypes of osteoarthritis: current state and future implications.
Leticia A Deveza, Amanda E Nelson, Richard F Loeser.
Clin Exp Rheumatol, 2019 Oct 18; 37 Suppl 120(5). PMID: 31621574    Free PMC article.
Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4.
Xin Duan, Guangcheng Guo, +4 authors, Xinguang Qiu.
Onco Targets Ther, 2020 Jan 08; 12. PMID: 31908485    Free PMC article.
ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future.
Brett Rozeboom, Nandini Dey, Pradip De.
Am J Cancer Res, 2020 Jan 09; 9(12). PMID: 31911865    Free PMC article.
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
Weikai Xiao, Shaoquan Zheng, +4 authors, Xiaoming Xie.
Aging (Albany NY), 2019 Dec 21; 11(24). PMID: 31857500    Free PMC article.
Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Judith A Malmgren, Gregory S Calip, +2 authors, Henry G Kaplan.
Cancer, 2019 Oct 23; 126(2). PMID: 31639221    Free PMC article.
Evidence-Based Network Approach to Recommending Targeted Cancer Therapies.
Jayaram Kancherla, Shruti Rao, +5 authors, Simina M Boca.
JCO Clin Cancer Inform, 2020 Jan 29; 4. PMID: 31990579    Free PMC article.
The role of RICTOR amplification in targeted therapy and drug resistance.
Deze Zhao, Man Jiang, Xiaochun Zhang, Helei Hou.
Mol Med, 2020 Feb 12; 26(1). PMID: 32041519    Free PMC article.
LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer.
Peng Li, Bo Zhou, Yuetao Lv, Qian Qian.
Hum Cell, 2019 Aug 29; 32(4). PMID: 31456112
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
Nobuhiko Takahashi, Hirotaka Hoshi, +11 authors, Motoki Takagi.
Cells, 2019 May 30; 8(5). PMID: 31137590    Free PMC article.
Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis.
Malachi A Blundon, Subhamoy Dasgupta.
Endocrinology, 2019 Jun 04; 160(8). PMID: 31157867    Free PMC article.
Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs.
Simona Punzi, Marine Meliksetian, +11 authors, Luisa Lanfrancone.
Cells, 2019 Jun 21; 8(6). PMID: 31216647    Free PMC article.
Metalloporphyrin Pd(T4) Exhibits Oncolytic Activity and Cumulative Effects with 5-ALA Photodynamic Treatment against C918 Cells.
Brandon Leviskas, Tibor Valyi-Nagy, +3 authors, Troy Skwor.
Int J Mol Sci, 2020 Jan 24; 21(2). PMID: 31968535    Free PMC article.
A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.
Salvador Harguindey, Khalid Alfarouk, +4 authors, Jesús Devesa.
Int J Mol Sci, 2020 Feb 13; 21(3). PMID: 32046158    Free PMC article.
LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Chunyong Han, Yiwei Fu, +2 authors, Qian Li.
Aging (Albany NY), 2020 Feb 20; 12(4). PMID: 32074085    Free PMC article.
Rab22a is a novel prognostic marker for cell progression in breast cancer.
Miao He, Leihua Shen, +7 authors, Zhaoying Yang.
Int J Mol Med, 2020 Mar 04; 45(4). PMID: 32124943    Free PMC article.
Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
Shaoquan Zheng, Lu Yang, +6 authors, Xiaoming Xie.
J Hematol Oncol, 2020 Mar 07; 13(1). PMID: 32138762    Free PMC article.
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy.
Xiaohan Zhou, Kun Shi, +4 authors, Zhiyong Qian.
Asian J Pharm Sci, 2020 Mar 17; 15(1). PMID: 32175016    Free PMC article.
An Overview of Vasculogenic Mimicry in Breast Cancer.
Marco A Andonegui-Elguera, Yair Alfaro-Mora, +3 authors, José Díaz-Chávez.
Front Oncol, 2020 Mar 17; 10. PMID: 32175277    Free PMC article.
Aloe-Emodin Induces Breast Tumor Cell Apoptosis through Upregulation of miR-15a/miR-16-1 That Suppresses BCL2.
Xuefeng Jiang, Yusheng Liu, +5 authors, Min Ma.
Evid Based Complement Alternat Med, 2020 Mar 20; 2020. PMID: 32190086    Free PMC article.
Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer.
Meizhuo Gao, Tie Wang, +3 authors, Hongjiang Song.
Front Immunol, 2020 Mar 21; 11. PMID: 32194569    Free PMC article.
Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.
Hongzhi Li, Weihua Yuan, +7 authors, Haihua Gu.
Am J Cancer Res, 2020 Mar 21; 10(2). PMID: 32195036    Free PMC article.
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study.
Yi Li, Chengcheng Gong, +7 authors, Biyun Wang.
Front Oncol, 2020 Mar 21; 10. PMID: 32195186    Free PMC article.
Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score.
Weiqi Gao, Lin Lin, +2 authors, Kunwei Shen.
J Cancer, 2020 Mar 24; 11(9). PMID: 32201521    Free PMC article.
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
Oza Zaheed, Julia Samson, Kellie Dean.
Noncoding RNA Res, 2020 Mar 25; 5(2). PMID: 32206740    Free PMC article.
Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer.
Catherine Knowlson, Paula Haddock, +3 authors, Niamh E Buckley.
Ther Adv Med Oncol, 2020 Mar 28; 12. PMID: 32215056    Free PMC article.
OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy Data.
Hayley M Dingerdissen, Frederic Bastian, +12 authors, Raja Mazumder.
JCO Clin Cancer Inform, 2020 Mar 07; 4. PMID: 32142370    Free PMC article.
Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
Xixi Dou, Pingzhen Tong, +8 authors, Dezhong Joshua Liao.
J Cancer, 2020 Apr 01; 11(10). PMID: 32226506    Free PMC article.
Drug repurposing for breast cancer therapy: Old weapon for new battle.
Sadhna Aggarwal, Sumit Singh Verma, Sumit Aggarwal, Subash Chandra Gupta.
Semin Cancer Biol, 2019 Sep 25; 68. PMID: 31550502    Free PMC article.
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis.
Shanawaz M Ghouse, Hong-My Nguyen, +2 authors, Dipongkor Saha.
Front Oncol, 2020 Apr 09; 10. PMID: 32266155    Free PMC article.
Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models.
Po-Han Lin, Yi-Fen Chiang, +8 authors, Shih-Min Hsia.
Antioxidants (Basel), 2020 Mar 14; 9(3). PMID: 32164337    Free PMC article.
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment.
Luka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak.
Cancers (Basel), 2020 Feb 29; 12(3). PMID: 32106399    Free PMC article.
Prognostic nomogram based on immune scores for breast cancer patients.
Ju Wang, Yanling Li, +4 authors, Xiaowei Qi.
Cancer Med, 2019 Jul 26; 8(11). PMID: 31342666    Free PMC article.
Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer.
Na Yang, Chang Wang, +6 authors, BangLao Xu.
J Cell Mol Med, 2019 Jul 31; 23(9). PMID: 31359594    Free PMC article.
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer.
Tian-Fu Li, Hui-Juan Zeng, +7 authors, Ying Lin.
Cancer Cell Int, 2020 Apr 24; 20. PMID: 32322170    Free PMC article.
In Vitro MCF-7 Cells Apoptosis Analysis of Carboplatin Loaded Silk Fibroin Particles.
Nanyak Galam, Pinar Tulay, Terin Adali.
Molecules, 2020 Mar 07; 25(5). PMID: 32131498    Free PMC article.
Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles.
Candace M Day, Shane M Hickey, +2 authors, Sanjay Garg.
Molecules, 2020 Mar 11; 25(5). PMID: 32151063    Free PMC article.
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part II: Metastatic Disease.
Addie Hill, Eutiquio Gutierrez, +3 authors, Mina S Sedrak.
Drugs Aging, 2020 Apr 01; 37(5). PMID: 32227289    Free PMC article.
Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing.
Yue Zhang, Di Wang, +2 authors, Yi-Qun Che.
PeerJ, 2020 May 02; 8. PMID: 32355577    Free PMC article.
First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
Tatsunori Shimoi, Yasuaki Sagara, +2 authors, Hiroji Iwata.
Breast Cancer, 2020 Feb 12; 27(3). PMID: 32043218    Free PMC article.
Systematic Review.
Relationship between red cell distribution width and prognosis in patients with breast cancer after operation: a retrospective cohort study.
Deshun Yao, Zhiwu Wang, +2 authors, Baosheng Li.
Biosci Rep, 2019 Jul 03; 39(7). PMID: 31262969    Free PMC article.
Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p.
Bo Wang, Yangyang Zhang, +7 authors, Qiyan Zeng.
Aging (Albany NY), 2020 Apr 20; 12(8). PMID: 32305959    Free PMC article.
Cellular Plasticity in Breast Cancer Progression and Therapy.
Deguang Kong, Connor J Hughes, Heide L Ford.
Front Mol Biosci, 2020 May 12; 7. PMID: 32391382    Free PMC article.
Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.
Jianli Chu, Dehong Yang, Ling Wang, Jielai Xia.
Ann Transl Med, 2020 May 16; 8(8). PMID: 32411767    Free PMC article.
Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Renee C Geck, Jackson R Foley, +3 authors, Alex Toker.
J Biol Chem, 2020 Mar 07; 295(19). PMID: 32139506    Free PMC article.
Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene.
Christopher Butler, Samuel Sprowls, +11 authors, Tuoen Liu.
Transl Oncol, 2020 May 15; 13(6). PMID: 32408199    Free PMC article.
Novel antibody-drug conjugates for triple negative breast cancer.
Aiko Nagayama, Neelima Vidula, Leif Ellisen, Aditya Bardia.
Ther Adv Med Oncol, 2020 May 20; 12. PMID: 32426047    Free PMC article.
Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rayna Rosati, Kailey Oppat, +2 authors, Manohar Ratnam.
BMC Cancer, 2020 Jun 05; 20(1). PMID: 32493230    Free PMC article.
Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast Cancer.
Nicholas E Wojtynek, Madeline T Olson, +6 authors, Aaron M Mohs.
Mol Imaging Biol, 2019 Dec 11; 22(4). PMID: 31820350    Free PMC article.
Proapoptotic and Antiangiogenic Activities of Arctium Lappa L. on Breast Cancer Cell Lines.
Mohamad Taleb Agha, Hussein M Baharetha, +4 authors, Amin Malik Shah Abdul Majid.
Scientifica (Cairo), 2020 Jun 09; 2020. PMID: 32509375    Free PMC article.
Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells.
Gang Xu, Shanshan Bu, +2 authors, Hong Ge.
Cancer Cell Int, 2020 Jun 11; 20. PMID: 32518527    Free PMC article.
The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017.
Peng Ji, Yue Gong, +3 authors, Zhi-Ming Shao.
Front Oncol, 2020 Jun 13; 10. PMID: 32528870    Free PMC article.
Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells.
Jinyan Shen, Li Li, +2 authors, Gongqin Sun.
Cancers (Basel), 2020 May 01; 12(5). PMID: 32349331    Free PMC article.
Large-Scale Differential Gene Expression Transcriptomic Analysis Identifies a Metabolic Signature Shared by All Cancer Cells.
Areej Abu Rmaileh, Balakrishnan Solaimuthu, +5 authors, Yoav D Shaul.
Biomolecules, 2020 May 06; 10(5). PMID: 32365991    Free PMC article.
Long Non-Coding RNA HOTAIR in Breast Cancer Therapy.
Monica Cantile, Maurizio Di Bonito, +3 authors, Gerardo Botti.
Cancers (Basel), 2020 May 14; 12(5). PMID: 32397382    Free PMC article.
Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers.
Simona Taverna, Ilaria Giusti, +2 authors, Vincenza Dolo.
Int J Mol Sci, 2020 May 24; 21(10). PMID: 32443642    Free PMC article.
LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
Li Han, Yuanyuan Yan, +7 authors, Minjie Wei.
J Cell Mol Med, 2020 Apr 21; 24(11). PMID: 32307830    Free PMC article.
Inhibition of PIM1 attenuates the stem cell-like traits of breast cancer cells by promoting RUNX3 nuclear retention.
Hui Liu, Cheng Chen, +4 authors, Chenxi Xiang.
J Cell Mol Med, 2020 Apr 21; 24(11). PMID: 32307917    Free PMC article.
Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
Chunai Gong, Xiaoyan Yu, +6 authors, Yongfang Yuan.
J Nanobiotechnology, 2020 Jun 18; 18(1). PMID: 32546174    Free PMC article.
RDGN-based predictive model for the prognosis of breast cancer.
Bing Dong, Ming Yi, +2 authors, Kongming Wu.
Exp Hematol Oncol, 2020 Jun 19; 9. PMID: 32550045    Free PMC article.
Drug utilization and expenditure of anticancer drugs for breast cancer.
Bander Balkhi, Saeed Alqahtani, +4 authors, Yousif Asiri.
Saudi Pharm J, 2020 Jun 20; 28(6). PMID: 32550797    Free PMC article.
Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients.
Shin-Mae Wang, Po-Ming Chen, +3 authors, Pei-Yi Chu.
J Oncol, 2020 Jun 23; 2020. PMID: 32565804    Free PMC article.
Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
Erik Heeg, Perla J Marang-van de Mheen, +5 authors, Marie-Jeanne T F D Vrancken Peeters.
Int J Cancer, 2019 Nov 14; 147(1). PMID: 31721193    Free PMC article.
Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review.
Julian Matthias Metzler, Laurin Burla, Daniel Fink, Patrick Imesch.
Int J Mol Sci, 2020 Jun 14; 21(11). PMID: 32532074    Free PMC article.
Systematic Review.
Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology.
Kailin Yang, Liuting Zeng, +4 authors, Lifang Liu.
Front Pharmacol, 2020 Jul 01; 11. PMID: 32595497    Free PMC article.
Monitoring Value of Serum HER2 as a Predictive Biomarker in Patients with Metastatic Breast Cancer.
Pengyu Zhang, Jun Xiao, +2 authors, Xuejun Zhang.
Cancer Manag Res, 2020 Jul 02; 12. PMID: 32606958    Free PMC article.
LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p.
Shuqin Zhang, Bin Wang, +7 authors, Saijun Fan.
Thorac Cancer, 2020 May 07; 11(7). PMID: 32374522    Free PMC article.
TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Jianing Tang, Yongwen Luo, +4 authors, Gaosong Wu.
Neoplasia, 2020 Jul 01; 22(9). PMID: 32599554    Free PMC article.
Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer.
Dat Nguyen, John Yu, William C Reinhold, Sherry X Yang.
JAMA Netw Open, 2020 Jul 10; 3(7). PMID: 32644137    Free PMC article.
Healthcare utilization among breast cancer patients during the COVID-19 outbreak.
Shiri Shinan-Altman, Inbar Levkovich, Guy Tavori.
Palliat Support Care, 2020 Jul 01; 18(4). PMID: 32594966    Free PMC article.
A Novel Circular RNA hsa_circRPPH1_015 Exerts an Oncogenic Role in Breast Cancer by Impairing miRNA-326-Mediated ELK1 Inhibition.
Chunming Zhao, Linlin Li, +5 authors, Rui Jiang.
Front Oncol, 2020 Jul 17; 10. PMID: 32670874    Free PMC article.
A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis.
Jin Hong, Jiahui Huang, +10 authors, Kunwei Shen.
BMC Cancer, 2020 Jul 18; 20(1). PMID: 32677982    Free PMC article.
Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.
Divya Bafna, Fuqiang Ban, +2 authors, Artem Cherkasov.
Int J Mol Sci, 2020 Jun 18; 21(12). PMID: 32545494    Free PMC article.
Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer.
Jiande Wu, Tarun Karthik Kumar Mamidi, Lu Zhang, Chindo Hicks.
Cancers (Basel), 2020 Jun 18; 12(6). PMID: 32545594    Free PMC article.
Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants.
Reem Saleh, Salman M Toor, +2 authors, Eyad Elkord.
Genes (Basel), 2020 Jul 04; 11(6). PMID: 32616706    Free PMC article.
A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines.
Shailima Rampogu, Seong Min Kim, +7 authors, Keun Woo Lee.
Biomolecules, 2020 Jun 10; 10(6). PMID: 32512851    Free PMC article.
Teaching cross-cultural design thinking for healthcare.
Mafalda Falcão Ferreira, Julia N Savoy, Mia K Markey.
Breast, 2020 Jan 21; 50. PMID: 31958660    Free PMC article.
Health state utilities for metastatic breast cancer in Taiwan.
Tzu-Chun Chou, Shao-Chin Chiang, Yu Ko.
Breast, 2020 Mar 28; 51. PMID: 32213442    Free PMC article.
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Yuichi Mitobe, Kazuhiro Ikeda, +8 authors, Satoshi Inoue.
Cancer Sci, 2020 May 22; 111(7). PMID: 32437068    Free PMC article.
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Yongqi Zhen, Rongyan Zhao, +5 authors, Xian-Li Zhou.
Theranostics, 2020 Jul 30; 10(18). PMID: 32724459    Free PMC article.
Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.
Doris Leithner, Marius E Mayerhoefer, +4 authors, Katja Pinker.
J Clin Med, 2020 Jun 18; 9(6). PMID: 32545851    Free PMC article.
Minimizing Delays in the Breast Cancer Pathway by Integrating Breast Specialty Care Services at the Primary Health Care Level in Zambia.
Mutumba Songiso, Leeya F Pinder, +5 authors, Groesbeck P Parham.
JCO Glob Oncol, 2020 Jun 25; 6. PMID: 32579485    Free PMC article.
Ca2+ as a therapeutic target in cancer.
Scott Gross, Pranava Mallu, +3 authors, Jonathan Soboloff.
Adv Cancer Res, 2020 Jul 30; 148. PMID: 32723565    Free PMC article.
Palbociclib-Induced Pneumonitis: A Case Report and Review of the Literature.
Saro Sarkisian, Christopher Markosian, Zeeshan Ali, Muhammad Rizvi.
Cureus, 2020 Aug 08; 12(6). PMID: 32760629    Free PMC article.
Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Siyuan Gan, Haixia Dai, +7 authors, Yanqin Sun.
Gland Surg, 2020 Aug 11; 9(3). PMID: 32775256    Free PMC article.
The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells.
Zuhier A Awan, Usama A Fahmy, +12 authors, Giuseppe Caruso.
Pharmaceutics, 2020 Jul 02; 12(7). PMID: 32604984    Free PMC article.
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding.
Fabian Baltes, Julia Caspers, +2 authors, Gerd Bendas.
Int J Mol Sci, 2020 Jul 17; 21(14). PMID: 32668815    Free PMC article.
The Premature Senescence in Breast Cancer Treatment Strategy.
Małgorzata Milczarek.
Cancers (Basel), 2020 Jul 10; 12(7). PMID: 32640718    Free PMC article.
Exosomal MicroRNAs and Organotropism in Breast Cancer Metastasis.
Grace L Wong, Sara Abu Jalboush, Hui-Wen Lo.
Cancers (Basel), 2020 Jul 11; 12(7). PMID: 32646059    Free PMC article.
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Rosamaria Lappano, Marianna Talia, +8 authors, Marcello Maggiolini.
J Exp Clin Cancer Res, 2020 Aug 12; 39(1). PMID: 32778144    Free PMC article.
MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells.
Yiqun Du, Jian Zhang, +3 authors, Zhiqiang Wu.
AMB Express, 2020 Aug 02; 10(1). PMID: 32737620    Free PMC article.
A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies.
Jialin Qu, Li Wang, +5 authors, Xiaochun Zhang.
Cancer Manag Res, 2020 Aug 18; 12. PMID: 32801888    Free PMC article.
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
Jinrui Zhang, Shuyan Liu, +13 authors, Han Liu.
Cell Death Differ, 2020 Apr 25; 27(9). PMID: 32327714    Free PMC article.
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.
John A Katzenellenbogen.
Nucl Med Biol, 2020 Apr 02; 92. PMID: 32229068    Free PMC article.
Cancer therapy: Attempt cure or manage drug resistance?
Elsa Hansen, Andrew F Read.
Evol Appl, 2020 Aug 22; 13(7). PMID: 32821276    Free PMC article.
Mukonal exerts anticancer effects on the human breast cancer cells by inducing autophagy and apoptosis and inhibits the tumor growth in vivo.
Wenbiao Wang, Zhengui Zhou, +3 authors, Zhengjun Jing.
AMB Express, 2020 Aug 19; 10(1). PMID: 32809085    Free PMC article.
Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients.
Erjie Zhao, Yujia Lan, +5 authors, Jing Hu.
Front Genet, 2020 Aug 28; 11. PMID: 32849766    Free PMC article.
Early Death Incidence and Prediction in Stage IV Breast Cancer.
Yumei Zhao, Guijun Xu, +9 authors, Chao Zhang.
Med Sci Monit, 2020 Aug 12; 26. PMID: 32778637    Free PMC article.
Left-right breast asymmetry and risk of screen-detected and interval cancers in a large population-based screening population.
Sue M Hudson, Louise S Wilkinson, Bianca L De Stavola, Isabel Dos-Santos-Silva.
Br J Radiol, 2020 Jun 12; 93(1112). PMID: 32525693    Free PMC article.
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Weidong Xu, Yuefeng Yang, +12 authors, Prem Seth.
Hum Gene Ther, 2020 May 13; 31(15-16). PMID: 32394753    Free PMC article.
Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Haiquan Lu, Yangyiran Xie, +6 authors, Gregg L Semenza.
J Clin Invest, 2020 May 20; 130(9). PMID: 32427586    Free PMC article.
Dietary intervention, a promising adjunct for cancer therapy.
Rongchen Shi, Hongming Miao.
Signal Transduct Target Ther, 2020 Aug 26; 5(1). PMID: 32839431    Free PMC article.
Aromatase Inhibitors-Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects.
Sara Tenti, Pierpaolo Correale, +2 authors, Luigi Pirtoli.
Int J Mol Sci, 2020 Aug 13; 21(16). PMID: 32781535    Free PMC article.
Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer.
Qing-Yu Yao, Jian Li, +5 authors, Tian-Yan Zhou.
Acta Pharmacol Sin, 2019 Jun 06; 40(12). PMID: 31165782    Free PMC article.
Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer.
Barbara Bennani-Baiti, Katja Pinker, +6 authors, Andreas Stadlbauer.
Cancers (Basel), 2020 Jul 30; 12(8). PMID: 32721996    Free PMC article.
Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
Yuqi Lin, Wen Zhang, +2 authors, Wei Du.
Genes (Basel), 2020 Aug 08; 11(8). PMID: 32759821    Free PMC article.
Effect of Hydrophobicity on the Anticancer Activity of Fatty-Acyl-Conjugated CM4 in Breast Cancer Cells.
Yunqing Yang, Huidan Zhang, +4 authors, Yuqing Chen.
ACS Omega, 2020 Sep 10; 5(34). PMID: 32905373    Free PMC article.
Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review.
Marta Maes-Carballo, Luciano Mignini, +2 authors, Khalid Saeed Khan.
Breast, 2020 Aug 29; 53. PMID: 32858405    Free PMC article.
Systematic Review.
Regulation of breast cancer metastasis signaling by miRNAs.
Belinda J Petri, Carolyn M Klinge.
Cancer Metastasis Rev, 2020 Jun 25; 39(3). PMID: 32577859    Free PMC article.
Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives.
María Ángeles Ávila-Gálvez, Juan Antonio Giménez-Bastida, Juan Carlos Espín, Antonio González-Sarrías.
Int J Mol Sci, 2020 Aug 14; 21(16). PMID: 32784973    Free PMC article.
Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study.
Bolun Ai, Xiangyu Wang, +3 authors, Jing Wang.
J Cancer, 2020 Sep 12; 11(19). PMID: 32913471    Free PMC article.
STAT3-mediated Apoptotic-enhancing Function of Sclareol Against Breast Cancer Cells and Cell Sensitization to Cyclophosphamide.
Havva Afshari, Mitra Nourbakhsh, +3 authors, Shokoofe Noori.
Iran J Pharm Res, 2020 Sep 15; 19(1). PMID: 32922496    Free PMC article.
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
Roberta Sommaggio, Elisa Cappuzzello, +5 authors, Antonio Rosato.
Oncoimmunology, 2020 Sep 15; 9(1). PMID: 32923140    Free PMC article.
Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
Jie Li, Maoguang Ma, +8 authors, Nu Zhang.
Mol Cancer, 2020 Sep 13; 19(1). PMID: 32917240    Free PMC article.
An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
Xiaotong Zhang, Gengyi Zou, +8 authors, Yi Shi.
Cancer Biol Med, 2020 Sep 19; 17(3). PMID: 32944400    Free PMC article.
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.
Michal Vocka, Martina Zimovjanova, +23 authors, Zdenek Kleibl.
Cancers (Basel), 2019 May 31; 11(6). PMID: 31141992    Free PMC article.
Risk of Cardiomyopathy in Breast Cancer: How Can We Attenuate the Risk of Heart Failure from Anthracyclines and Anti-HER2 Therapies?
Gretchen Kimmick, Susan Dent, Igor Klem.
Curr Treat Options Cardiovasc Med, 2019 Jun 04; 21(6). PMID: 31152324
The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo.
Gloria Allocca, Russell Hughes, +4 authors, Ingunn Holen.
J Bone Oncol, 2019 Jun 27; 17. PMID: 31236323    Free PMC article.
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
Charles C N Wang, Chia Ying Li, +5 authors, Ming-Feng Hou.
J Clin Med, 2019 Aug 07; 8(8). PMID: 31382519    Free PMC article.
Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo.
Qun Zhao, Yingxiang Liu, +7 authors, Xianjun Yu.
Cell Death Discov, 2019 Aug 10; 5. PMID: 31396402    Free PMC article.
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience.
Salvatore Del Prete, Michele Caraglia, +11 authors, Raffaele Addeo.
Oncol Lett, 2019 Sep 14; 18(4). PMID: 31516598    Free PMC article.
Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial-to-mesenchymal transition via slug in MCF-7 breast cancer cells.
Yingsheng Xiao, Qin Xie, +3 authors, De Zeng.
J Cell Physiol, 2020 Feb 12; 235(10). PMID: 32043610    Free PMC article.
Synergistic Interactions of 5-Fluorouracil with Inhibitors of Protein Kinase CK2 Correlate with p38 MAPK Activation and FAK Inhibition in the Triple-Negative Breast Cancer Cell Line.
Patrycja Wińska, Olena Karatsai, +3 authors, Maria Jolanta Rędowicz.
Int J Mol Sci, 2020 Sep 03; 21(17). PMID: 32872257    Free PMC article.
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling.
Hui Shi, Luping Zhao, +13 authors, Huabao Xiong.
Int J Mol Sci, 2020 Sep 06; 21(17). PMID: 32887217    Free PMC article.
Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
Giulia Bicchierai, Francesco Amato, +9 authors, Jacopo Nori.
Breast, 2020 Sep 06; 54. PMID: 32889303    Free PMC article.
Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial-Mesenchymal Transition.
Jialiang Wen, Lizhi Lin, +3 authors, Ouchen Wang.
Cancer Manag Res, 2020 Sep 29; 12. PMID: 32982454    Free PMC article.
Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer.
Tao Xu, Zhi Wang, +3 authors, Xingrui Li.
Aging (Albany NY), 2020 Sep 12; 12(17). PMID: 32915772    Free PMC article.
Soft Microenvironments Induce Chemoresistance by Increasing Autophagy Downstream of Integrin-Linked Kinase.
Alişya A Anlaş, Celeste M Nelson.
Cancer Res, 2020 Oct 04; 80(19). PMID: 33008805    Free PMC article.
Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study.
Linbang Wang, Yuanyuan Wang, +8 authors, Jinxiang Tan.
Sci Rep, 2020 Oct 07; 10(1). PMID: 33020551    Free PMC article.
Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
Demetria Smith-Graziani, Xiudong Lei, +3 authors, Mariana Chavez-MacGregor.
Cancer Med, 2020 Aug 09; 9(19). PMID: 32767723    Free PMC article.
A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
Caijin Lin, Jiayi Wu, +8 authors, Li Zhu.
Front Oncol, 2020 Oct 13; 10. PMID: 33042787    Free PMC article.
Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, +31 authors, Martin Widschwendter.
Nat Rev Clin Oncol, 2020 Jun 20; 17(11). PMID: 32555420    Free PMC article.
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.
Anna Barkovskaya, Kotryna Seip, +3 authors, Harri M Itkonen.
Sci Rep, 2020 Oct 14; 10(1). PMID: 33046784    Free PMC article.
Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis.
Mingqian Hao, Wencong Liu, +9 authors, Yinan Zheng.
PeerJ, 2020 Oct 22; 8. PMID: 33083112    Free PMC article.
Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts.
Daehyun Kim, Seung Soo Lee, +6 authors, Hak Jong Lee.
Pharmaceuticals (Basel), 2020 Sep 11; 13(9). PMID: 32906686    Free PMC article.
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis.
Ying Lin, Mingxi Lin, +7 authors, Xichun Hu.
Cancer Res Treat, 2020 Apr 28; 52(4). PMID: 32340083    Free PMC article.
LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Chuang Du, Yan Wang, +3 authors, Jingruo Li.
Cell Transplant, 2020 Jul 21; 29. PMID: 32686982    Free PMC article.
Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States.
Lina Jansen, Bernd Holleczek, +12 authors, Hermann Brenner.
Cancers (Basel), 2020 Aug 30; 12(9). PMID: 32858964    Free PMC article.
The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies.
Giuseppina Augimeri, Cinzia Giordano, +5 authors, Daniela Bonofiglio.
Cancers (Basel), 2020 Sep 18; 12(9). PMID: 32937951    Free PMC article.
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer.
Parama Dey, Alexander Wang, +4 authors, Benita S Katzenellenbogen.
Cancers (Basel), 2020 Sep 24; 12(9). PMID: 32961773    Free PMC article.
Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer.
Suzanne Bakewell, Isabel Conde, +3 authors, Ayesha N Shajahan-Haq.
Cancers (Basel), 2020 Sep 20; 12(9). PMID: 32947941    Free PMC article.
Forkhead box P3 promotes breast cancer cell apoptosis by regulating programmed cell death 4 expression.
Dong Fan, Cheng Zeng, +6 authors, Ying Xu.
Oncol Lett, 2020 Oct 27; 20(6). PMID: 33101486    Free PMC article.
Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study.
Vaiyapuri Subbarayan Periasamy, Anvarbatcha Riyasdeen, +4 authors, Mohammad Abdulkader Akbarsha.
Molecules, 2020 Oct 07; 25(19). PMID: 33019623    Free PMC article.
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis.
Karolina A Zielińska, Vladimir L Katanaev.
Cancers (Basel), 2020 Oct 25; 12(10). PMID: 33096815    Free PMC article.
Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity.
Lei Wang, Xusha Zhou, +4 authors, Grace Guoying Zhou.
J Nanobiotechnology, 2020 Oct 29; 18(1). PMID: 33109196    Free PMC article.
Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer.
Chang Liu, Qian Zhao, Xijie Yu.
Front Oncol, 2020 Oct 31; 10. PMID: 33123472    Free PMC article.
Do Olive and Fish Oils of the Mediterranean Diet Have a Role in Triple Negative Breast Cancer Prevention and Therapy? An Exploration of Evidence in Cells and Animal Models.
Micah G Donovan, Ornella I Selmin, +2 authors, Donato F Romagnolo.
Front Nutr, 2020 Oct 31; 7. PMID: 33123546    Free PMC article.
Anticancer Properties of Carnosol: A Summary of in Vitro and In Vivo Evidence.
Eric J O'Neill, Danja J Den Hartogh, Karim Azizi, Evangelia Tsiani.
Antioxidants (Basel), 2020 Oct 15; 9(10). PMID: 33049974    Free PMC article.
Lysimachia christinae Hance as an anticancer agent against breast cancer cells.
Hyun A Kim, Dong-Sung Lee, Hwan Lee, Joomin Lee.
Food Sci Nutr, 2020 Nov 03; 8(10). PMID: 33133573    Free PMC article.
Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring.
Jay V Shah, Amber Gonda, +10 authors, Vidya Ganapathy.
Front Mol Biosci, 2020 Nov 03; 7. PMID: 33134314    Free PMC article.
Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification.
Xiao-Fang Dong, Yan Wang, +5 authors, Chao-Qun Wang.
Biomed Res Int, 2020 Nov 03; 2020. PMID: 33134390    Free PMC article.
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Shaoquan Zheng, Yutian Zou, +6 authors, Xiaoming Xie.
Mol Oncol, 2020 Jun 11; 14(11). PMID: 32521117    Free PMC article.
Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial.
Junnan Xu, Yan Wang, +4 authors, Tao Sun.
Front Oncol, 2020 Nov 10; 10. PMID: 33163394    Free PMC article.
Action Items for Breast Cancer Awareness Month.
Deanna J Attai.
J Patient Cent Res Rev, 2020 Nov 10; 7(4). PMID: 33163548    Free PMC article.
Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis.
Wen-Jun Wang, Ling-Yu Li, Jiu-Wei Cui.
Epigenetics Chromatin, 2020 Nov 11; 13(1). PMID: 33168103    Free PMC article.
Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies.
Hui Lv, Ding Shi, +5 authors, Peiying Hu.
Front Oncol, 2020 Nov 13; 10. PMID: 33178584    Free PMC article.
Systematic Review.
Estimation of Risk of Recurrence and Toxicity Among Oncologists and Patients With Resected Breast Cancer: A Quantitative Study.
Laura Ciria-Suarez, Paula Jimenez-Fonseca, +2 authors, Caterina Calderon.
Front Psychol, 2020 Nov 17; 11. PMID: 33192784    Free PMC article.
Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
Xuemei Yang, Juan Li, +9 authors, Chuanxin Wang.
Front Oncol, 2020 Nov 17; 10. PMID: 33194577    Free PMC article.
Methylation-Mediated Silencing of MicroRNA-497 Promotes Breast Cancer Progression Through Up-Regulation of Mucin1.
Shuang Tao, Hong Li, +4 authors, Jinping Li.
Front Oncol, 2020 Nov 17; 10. PMID: 33194611    Free PMC article.
The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer.
Zhang-Zan Huang, Xin Hua, +5 authors, Jia-Jia Huang.
Front Oncol, 2020 Nov 17; 10. PMID: 33194636    Free PMC article.
Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem.
Feifan Zhou, Meng Wang, +2 authors, Wei R Chen.
Biomaterials, 2020 Sep 30; 265. PMID: 32992117    Free PMC article.
Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Hong Lin, Yanxuan Wu, Guoxi Liang, Liming Chen.
PLoS One, 2020 Nov 11; 15(11). PMID: 33170907    Free PMC article.
Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China.
Ran Feng, Jingfeng Jing, +2 authors, Jinnan Gao.
BMC Cancer, 2020 Nov 14; 20(1). PMID: 33183247    Free PMC article.
Resistance and Overcoming Resistance in Breast Cancer.
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas, Milena Rondón-Lagos.
Breast Cancer (Dove Med Press), 2020 Nov 19; 12. PMID: 33204149    Free PMC article.
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Wei Ma, Fangkun Zhao, +7 authors, Feng Jin.
J Transl Med, 2020 Nov 24; 18(1). PMID: 33225954    Free PMC article.
CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer.
Jianxin Wang, Guangchen Zhang, +6 authors, Changjun Wu.
Front Genet, 2020 Nov 27; 11. PMID: 33240323    Free PMC article.
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.
Yun-Ju Huang, Kai-Lee Wang, +2 authors, Shih-Min Hsia.
Biomolecules, 2020 Oct 30; 10(11). PMID: 33113766    Free PMC article.
Development of Innovative Formulations for Breast Cancer Chemotherapy.
Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez.
Cancers (Basel), 2020 Nov 12; 12(11). PMID: 33171899    Free PMC article.
The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
Lei Zhang, Ru Tang, +4 authors, Zhen-Yu He.
BMC Cancer, 2020 Nov 27; 20(1). PMID: 33238939    Free PMC article.
Folic Acid-Functionalized Composite Scaffolds of Gelatin and Gold Nanoparticles for Photothermal Ablation of Breast Cancer Cells.
Huajian Chen, Xiuhui Wang, +4 authors, Guoping Chen.
Front Bioeng Biotechnol, 2020 Dec 01; 8. PMID: 33251201    Free PMC article.
Prognositic significance of P-cadherin expression in breast cancer: Protocol for a meta-analysis.
Yupeng Xi, Xiwen Zhang, +6 authors, Baojin Hua.
Medicine (Baltimore), 2019 Mar 22; 98(12). PMID: 30896652    Free PMC article.
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.
Jiang-Jiang Qin, Li Yan, Jia Zhang, Wei-Dong Zhang.
J Exp Clin Cancer Res, 2019 May 16; 38(1). PMID: 31088482    Free PMC article.
Highly Cited. Systematic Review.
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors.
Mattia Garutti, Giacomo Pelizzari, +4 authors, Fabio Puglisi.
Int J Mol Sci, 2019 Jul 13; 20(14). PMID: 31295913    Free PMC article.
The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer.
María Inés Diaz Bessone, María José Gattas, +2 authors, Marina Simian.
Front Endocrinol (Lausanne), 2019 Aug 24; 10. PMID: 31440208    Free PMC article.
Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.
Daisuke Yamashita, Mutsuko Minata, +8 authors, Ichiro Nakano.
Mol Cancer Ther, 2020 Mar 05; 19(5). PMID: 32127468    Free PMC article.
Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.
Marta Maes-Carballo, Isabel Muñoz-Núñez, +3 authors, Khalid Saeed Khan.
Health Expect, 2020 Aug 05; 23(5). PMID: 32748514    Free PMC article.
Systematic Review.
A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
Zijian Liu, Mi Mi, +3 authors, Liling Zhang.
J Cell Mol Med, 2020 Sep 24; 24(21). PMID: 32967061    Free PMC article.
Drug Repurposing for Triple-Negative Breast Cancer.
Marta Ávalos-Moreno, Araceli López-Tejada, +5 authors, Sergio Granados-Principal.
J Pers Med, 2020 Nov 04; 10(4). PMID: 33138097    Free PMC article.
Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.
Matthias Barone, Matthias Müller, +20 authors, Ronald Kühne.
Proc Natl Acad Sci U S A, 2020 Nov 14; 117(47). PMID: 33184177    Free PMC article.
PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer.
Bo Chen, Jianguo Lai, +4 authors, Hailin Tang.
Ther Adv Med Oncol, 2020 Dec 08; 12. PMID: 33281951    Free PMC article.
Music intervention improves the physical and mental status for patients with breast cancer: A protocol of randomized controlled trial.
Xiuting Li, Guangpeng Du, Wei Liu, Fangfei Wang.
Medicine (Baltimore), 2020 Dec 09; 99(49). PMID: 33285746    Free PMC article.
Emerging roles of N6-methyladenosine (m6A) modification in breast cancer.
Yanyan Wang, Yujie Zhang, +3 authors, Suzhan Zhang.
Cell Biosci, 2020 Dec 10; 10(1). PMID: 33292526    Free PMC article.
Targeting ferroptosis in breast cancer.
Zhaoqing Li, Lini Chen, +10 authors, Jichun Zhou.
Biomark Res, 2020 Dec 10; 8(1). PMID: 33292585    Free PMC article.
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Mona Ebadi, Saifullah Bullo, +3 authors, Giorgia Pastorin.
Sci Rep, 2020 Dec 11; 10(1). PMID: 33298980    Free PMC article.
Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer.
Lijuan Lyu, Meng Wang, +10 authors, Huafeng Kang.
Cancer Manag Res, 2020 Dec 11; 12. PMID: 33299353    Free PMC article.
Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines.
Natalia Vargas-Rondón, Erika Pérez-Mora, Victoria E Villegas, Milena Rondón-Lagos.
Cancer Biol Med, 2020 Dec 11; 17(4). PMID: 33299647    Free PMC article.
Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
Jennifer A Weiss, Andrew Nicklawsky, +9 authors, Jennifer R Diamond.
Cancer Med, 2020 Oct 17; 9(23). PMID: 33063469    Free PMC article.
Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice.
Feng Ye, Yubo Liu, +4 authors, Jun Tang.
Cancer Med, 2020 Nov 05; 9(23). PMID: 33145946    Free PMC article.
Environmental control of mammary carcinoma cell expansion by acidification and spheroid formation in vitro.
Ana Carolina Lima Ralph, Iuri Cordeiro Valadão, +7 authors, Vanessa Morais Freitas.
Sci Rep, 2020 Dec 16; 10(1). PMID: 33319820    Free PMC article.
Targeting hydrogen sulphide signaling in breast cancer.
Rana Ahmed Youness, Ahmed Zakaria Gad, +7 authors, Mohamed Zakaria Gad.
J Adv Res, 2020 Dec 16; 27. PMID: 33318876    Free PMC article.
Hepatic Metastasis from Breast Cancer.
Ariel N Liberchuk, Amy R Deipolyi.
Semin Intervent Radiol, 2020 Dec 18; 37(5). PMID: 33328708    Free PMC article.
Bisphenols and Risk of Breast Cancer: A Narrative Review of the Impact of Diet and Bioactive Food Components.
Barbara J Stillwater, Ashleigh C Bull, +3 authors, Ornella I Selmin.
Front Nutr, 2020 Dec 18; 7. PMID: 33330580    Free PMC article.
Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda.
Angela T Mlole, James J Yahaya, +2 authors, Andrew L Okwi.
Int J Womens Health, 2020 Dec 22; 12. PMID: 33343201    Free PMC article.
Effect of prolonged expressive writing on health outcomes in breast cancer patients receiving chemotherapy: a multicenter randomized controlled trial.
Yanni Wu, Liping Liu, +9 authors, Chunlan Zhou.
Support Care Cancer, 2020 Jul 01; 29(2). PMID: 32601853
Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems.
Patrícia de Faria Lainetti, Antonio Fernando Leis-Filho, +2 authors, Carlos Eduardo Fonseca-Alves.
Pharmaceutics, 2020 Dec 16; 12(12). PMID: 33316872    Free PMC article.
Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study.
Ming Li, Jinbo Yue, +8 authors, Xuefeng Xia.
Front Oncol, 2020 Dec 29; 10. PMID: 33363018    Free PMC article.
Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Sha Li, Tsz-Him So, +6 authors, Yibin Feng.
Front Oncol, 2020 Dec 29; 10. PMID: 33363030    Free PMC article.
Systematic Review.
Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
Jiangping Yang, Jiaqi Han, +3 authors, Xi Yan.
Cancer Manag Res, 2020 Dec 29; 12. PMID: 33364838    Free PMC article.
Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer.
Dimitris Tsakogiannis, Eleni Kalogera, +3 authors, Garyfalia Bletsa.
Oncol Lett, 2020 Dec 31; 21(2). PMID: 33376518    Free PMC article.
Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer.
Harishini Rajaratinam, Nur Syahmina Rasudin, +5 authors, Wan Ezumi Mohd Fuad.
Oncol Lett, 2020 Dec 31; 21(2). PMID: 33376541    Free PMC article.
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.
Eduard Vrdoljak, Joseph Gligorov, +15 authors, Fatima Cardoso.
Breast, 2020 Dec 29; 55. PMID: 33360479    Free PMC article.
Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
Li Yue, Liu Wentao, +5 authors, Li Dalin.
Medicine (Baltimore), 2020 Dec 30; 99(51). PMID: 33371069    Free PMC article.
The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study.
José Pablo Leone, Bernardo Amadeo Leone, +5 authors, Julieta Leone.
Breast Cancer Res Treat, 2021 Jan 04; 187(1). PMID: 33389398
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
Che-Pei Kung, Kyle A Cottrell, +7 authors, Jason D Weber.
Oncogene, 2020 Oct 29; 40(1). PMID: 33110236    Free PMC article.
The immunomodulatory effects of endocrine therapy in breast cancer.
Huanhuan Huang, Jun Zhou, +4 authors, Chao Ni.
J Exp Clin Cancer Res, 2021 Jan 09; 40(1). PMID: 33413549    Free PMC article.
Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway.
Anqi Zeng, Xin Liang, +5 authors, Linjiang Song.
Oncol Rep, 2021 Jan 09; 45(2). PMID: 33416150    Free PMC article.
Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Siqi Bao, Ting Hu, +7 authors, Meng Zhou.
J Nanobiotechnology, 2021 Jan 14; 19(1). PMID: 33436002    Free PMC article.
DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
Jiazhe Liu, Hongchang Li, +4 authors, Gaofeng Pan.
Cell Cycle, 2020 Dec 11; 19(24). PMID: 33300431    Free PMC article.
DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments.
Linlong Mo, Jiayou Liu, +5 authors, Fang Fang.
Gland Surg, 2021 Jan 16; 9(6). PMID: 33447546    Free PMC article.
Application of digital mammography-based radiomics in the differentiation of benign and malignant round-like breast tumors and the prediction of molecular subtypes.
Lanyun Wang, Wenjun Yang, +6 authors, Bin Song.
Gland Surg, 2021 Jan 16; 9(6). PMID: 33447551    Free PMC article.
The expression of programmed death-ligand 1 in patients with invasive breast cancer.
Yi Meng, Hongyan Wu, Yongzhong Yao, Rong Li.
Gland Surg, 2021 Jan 16; 9(6). PMID: 33447561    Free PMC article.
Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p.
Jianhui Liu, Shaoliang Zhu, +3 authors, Huawei Yang.
Cancer Cell Int, 2021 Jan 17; 21(1). PMID: 33451320    Free PMC article.
Experience of women with breast cancer undergoing chemotherapy: a systematic review of qualitative research.
Liping Liu, Yanni Wu, +3 authors, Chunlan Zhou.
Qual Life Res, 2021 Jan 19; 30(5). PMID: 33459972
Systematic Review.
Magnitude and dosimetric impact of inter-fractional positional variations of the metal port of tissue expanders in postmastectomy patients treated with radiation.
Keren Mayorov, Elsayed Ali.
Phys Imaging Radiat Oncol, 2021 Jan 19; 16. PMID: 33458342    Free PMC article.
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
Xingfa Huo, Jinming Li, +5 authors, Jiuda Zhao.
BMC Cancer, 2021 Jan 21; 21(1). PMID: 33468087    Free PMC article.
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
Yuko Tanaka, Takashi Ohno, +7 authors, Yoshihisa Umekita.
Breast Cancer, 2021 Jan 23; 28(4). PMID: 33481184
Breast cancer: insights in disease and influence of drug methotrexate.
Vítor Yang, Maria João Gouveia, +4 authors, Nuno Vale.
RSC Med Chem, 2021 Jan 23; 11(6). PMID: 33479665    Free PMC article.
Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials.
Jananee Padayachee, Moganavelli Singh.
Nanobiomedicine (Rij), 2021 Jan 26; 7. PMID: 33488814    Free PMC article.
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells.
Rossana Galassi, Lorenzo Luciani, +6 authors, Stefania Pucciarelli.
Front Chem, 2021 Jan 26; 8. PMID: 33490036    Free PMC article.
Cancer photo-immunotherapy: from bench to bedside.
Miao Wang, Jie Rao, +6 authors, Feifan Zhou.
Theranostics, 2021 Jan 28; 11(5). PMID: 33500721    Free PMC article.
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.
Yi-Zhou Jiang, Yin Liu, +12 authors, Zhi-Ming Shao.
Cell Res, 2020 Jul 29; 31(2). PMID: 32719455    Free PMC article.
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.
Mary J Laws, Yvonne Ziegler, +8 authors, Benita S Katzenellenbogen.
Breast Cancer Res Treat, 2020 Apr 12; 181(2). PMID: 32277377    Free PMC article.
CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Ya Fan, Jia Wang, +5 authors, Dongming Su.
Mol Cancer, 2021 Feb 04; 20(1). PMID: 33530981    Free PMC article.
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
Shunchao Yan, Parama Dey, +4 authors, Benita S Katzenellenbogen.
Breast Cancer Res Treat, 2020 Oct 02; 185(2). PMID: 33001337    Free PMC article.
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer.
Christine Brezden-Masley, Kelly E Fathers, +3 authors, Katarzyna J Jerzak.
Breast Cancer Res Treat, 2020 Oct 17; 185(2). PMID: 33064230    Free PMC article.
Adult precision medicine: learning from the past to enhance the future.
Ashley Ghiaseddin, Lan B Hoang Minh, +5 authors, Stuart A Grossman.
Neurooncol Adv, 2021 Feb 06; 3(1). PMID: 33543142    Free PMC article.
The Venom of Philippine Tarantula (Theraphosidae) Contains Peptides with Pro-Oxidative and Nitrosative-Dependent Cytotoxic Activities against Breast Cancer Cells (MCF-7) In Vitro.
Simon Miguel M Lopez, Jeremey S Aguilar, +8 authors, Librado Santiago.
Asian Pac J Cancer Prev, 2020 Aug 29; 21(8). PMID: 32856874    Free PMC article.
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards.
R Danesi, S Fogli, +9 authors, P Conte.
ESMO Open, 2021 Feb 05; 6(2). PMID: 33540286    Free PMC article.
Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy.
Xuanbo Zhang, Jianchen Xiong, +12 authors, Jin Sun.
Bioact Mater, 2021 Feb 09; 6(8). PMID: 33553816    Free PMC article.
HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
Yu Zhou, Yuan Yuan, +11 authors, Chen Wang.
PLoS One, 2021 Feb 03; 16(2). PMID: 33529238    Free PMC article.
Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy.
Farrokh Dehdashti, Ningying Wu, +3 authors, Barry A Siegel.
Nat Commun, 2021 Feb 04; 12(1). PMID: 33531464    Free PMC article.
Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis.
Yimeng Chen, Yin Guan, +11 authors, Binghe Xu.
Ann Transl Med, 2021 Feb 12; 9(2). PMID: 33569411    Free PMC article.
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks.
Shunheng Zhou, Yu-E Huang, +5 authors, Wei Jiang.
Mol Ther Nucleic Acids, 2021 Feb 13; 23. PMID: 33575114    Free PMC article.
Arsenic hexoxide has differential effects on cell proliferation and genome-wide gene expression in human primary mammary epithelial and MCF7 cells.
Donguk Kim, Na Yeon Park, +4 authors, Heeyoun Bunch.
Sci Rep, 2021 Feb 14; 11(1). PMID: 33580144    Free PMC article.
The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.
Farhad Islami, Rebecca L Siegel, Ahmedin Jemal.
Nat Rev Clin Oncol, 2020 May 30; 17(10). PMID: 32467620
RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer.
Lin Yang, Shuangling Wu, +4 authors, Wei-Min Tong.
Front Oncol, 2021 Feb 16; 10. PMID: 33585234    Free PMC article.
Stimuli-Responsive, Plasmonic Nanogel for Dual Delivery of Curcumin and Photothermal Therapy for Cancer Treatment.
Fadak Howaili, Ezgi Özliseli, +3 authors, Jessica M Rosenholm.
Front Chem, 2021 Feb 16; 8. PMID: 33585400    Free PMC article.
Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer.
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, Gunes Ozhan.
Front Cell Dev Biol, 2021 Feb 16; 9. PMID: 33585487    Free PMC article.
Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
Jiaqi Liu, Hengqiang Zhao, +23 authors, Jianzhong Su.
Mol Cancer, 2021 Feb 21; 20(1). PMID: 33608029    Free PMC article.
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Marion Bertho, Julien Fraisse, +21 authors, Jean-Sébastien Frénel.
Ther Adv Med Oncol, 2021 Feb 23; 13. PMID: 33613700    Free PMC article.
Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis.
Songjie Shen, Yu Song, +4 authors, Qiang Sun.
Cell Commun Signal, 2021 Feb 24; 19(1). PMID: 33618729    Free PMC article.
[Cytotoxic effect of photodynamic liposome gel combined with trastuzumab on drugresistant breast cancer cells in vitro].
Y Wang, C Wen, +5 authors, M Yu.
Nan Fang Yi Ke Da Xue Xue Bao, 2021 Feb 25; 41(2). PMID: 33624588    Free PMC article.
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion.
Jae Heon Jeong, Jae Won Yun, +2 authors, Sejoon Lee.
J Clin Med, 2021 Feb 10; 10(4). PMID: 33557149    Free PMC article.
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.
Chi-Cheng Huang, Yi-Fang Tsai, +7 authors, Ling-Ming Tseng.
BMC Cancer, 2021 Feb 27; 21(1). PMID: 33632156    Free PMC article.
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Amparo Garcia-Tejedor, Sergi Fernandez-Gonzalez, +19 authors, Catalina Falo.
Breast Cancer Res Treat, 2020 Oct 18; 185(3). PMID: 33068198
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression.
Damiano Cosimo Rigiracciolo, Francesca Cirillo, +4 authors, Rosamaria Lappano.
Cancers (Basel), 2021 Feb 11; 13(4). PMID: 33562737    Free PMC article.
Nutritional Intervention Contributes to the Improvement of Symptoms Related to Quality of Life in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial.
Ana Priscilla Silva de Souza, Luciana Câmara da Silva, Ana Paula Trussardi Fayh.
Nutrients, 2021 Feb 14; 13(2). PMID: 33579050    Free PMC article.
Role of the mesenchymal stem cells derived from adipose tissue in changing the rate of breast cancer cell proliferation and autophagy, in vitro and in vivo.
Maryam Adelipour, Abdolamir Allameh, +5 authors, Sahar Golabi.
Iran J Basic Med Sci, 2021 Mar 02; 24(1). PMID: 33643577    Free PMC article.
Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple-Negative Breast Cancer Tumor Growth.
Yan Liu, Yehui Zhou, Xinxing Ma, Liming Chen.
Adv Sci (Weinh), 2021 Mar 02; 8(4). PMID: 33643800    Free PMC article.
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China.
Yun Wu, Yiqun Han, +24 authors, Binghe Xu.
Front Oncol, 2021 Mar 02; 10. PMID: 33643905    Free PMC article.
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.
Ashkan Shahbandi, Hoang D Nguyen, James G Jackson.
Trends Cancer, 2020 Feb 18; 6(2). PMID: 32061310    Free PMC article.
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer.
Xiangdong Lv, Lacey E Dobrolecki, +3 authors, Xi Chen.
J Vis Exp, 2020 Jun 02; (159). PMID: 32478757    Free PMC article.
RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation.
Tingting Li, Xian Wang, +5 authors, Shou-Jiang Gao.
Nat Commun, 2021 Feb 18; 12(1). PMID: 33594058    Free PMC article.
Association of relative dose intensity with BMI and pathologic complete response in patients treated with neoadjuvant chemotherapy for breast cancer.
Ilana Usiskin, Fangyong Li, +2 authors, Tara Sanft.
Breast Cancer Res Treat, 2020 Oct 31; 186(1). PMID: 33125620
Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer.
Christen A Khella, Gaurav A Mehta, Rushabh N Mehta, Michael L Gatza.
J Pers Med, 2021 Mar 07; 11(2). PMID: 33669749    Free PMC article.
Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Yanchun Qu, Yufeng Liu, +3 authors, Haibo Zhang.
Onco Targets Ther, 2021 Mar 11; 14. PMID: 33688205    Free PMC article.
Evaluation of personalized cancer therapies based on comprehensive genomic profiling in a middle-sized oncologic center in Austria, the University Clinic Krems.
Josef Singer, Elias Brauneck, Elisabeth Zwickl-Traxler, Martin Pecherstorfer.
Transl Oncol, 2021 Feb 24; 14(5). PMID: 33621740    Free PMC article.
FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.
Lu Xu, Ji-Ming Shen, +9 authors, Yue-E Teng.
Ann Transl Med, 2021 Mar 13; 9(3). PMID: 33708885    Free PMC article.
Role of the NUDT Enzymes in Breast Cancer.
Roni H G Wright, Miguel Beato.
Int J Mol Sci, 2021 Mar 07; 22(5). PMID: 33668737    Free PMC article.
Preclinical Models to Study Obesity and Breast Cancer in Females: Considerations, Caveats, and Tools.
Erin D Giles, Elizabeth A Wellberg.
J Mammary Gland Biol Neoplasia, 2020 Nov 05; 25(4). PMID: 33146844    Free PMC article.
Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer.
Vignesh Sivaganesh, Nazifa Promi, Salma Maher, Bela Peethambaran.
Int J Mol Sci, 2021 Mar 07; 22(5). PMID: 33670942    Free PMC article.
The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer.
Liting Tang, Baohong Jiang, +6 authors, Yuehua Li.
Front Oncol, 2021 Mar 16; 11. PMID: 33718157    Free PMC article.
A novel radiolytic rotenone derivative, rotenoisin A, displays potent anticarcinogenic activity in breast cancer cells.
Dong-Ho Bak, Seong Hee Kang, +2 authors, Hyoung-Woo Bai.
J Radiat Res, 2021 Feb 23; 62(2). PMID: 33615367    Free PMC article.
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Jialang Zhuang, Siqi Chen, +3 authors, Ni Xie.
Int J Nanomedicine, 2021 Mar 18; 16. PMID: 33727809    Free PMC article.
MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4.
Bo Lin, Chunhua Liu, +4 authors, Runyuan Ji.
BMC Cancer, 2021 Mar 17; 21(1). PMID: 33722196    Free PMC article.
Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.
Narmadhaa Siva, Sonal Gupta, +3 authors, Nidhi Shukla.
3 Biotech, 2021 Mar 19; 11(3). PMID: 33732568    Free PMC article.
Comparative Analysis of Paper-Based and Web-Based Versions of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) Questionnaire in Breast Cancer Patients: Randomized Crossover Study.
Jinfei Ma, Zihao Zou, +3 authors, Feng Jin.
JMIR Med Inform, 2021 Mar 03; 9(3). PMID: 33650978    Free PMC article.
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
Hanyi Fang, Yongkang Gai, +8 authors, Xiaoli Lan.
J Nanobiotechnology, 2021 Mar 22; 19(1). PMID: 33743740    Free PMC article.
Clinical application of circulating tumor DNA in breast cancer.
Jeffrey Chun Hin Chan, James Chung Hang Chow, +2 authors, William C Cho.
J Cancer Res Clin Oncol, 2021 Mar 25; 147(5). PMID: 33760943
In Vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review.
Alicia S Ombredane, Vitória R P Silva, +10 authors, Graziella A Joanitti.
Front Oncol, 2021 Mar 27; 11. PMID: 33767985    Free PMC article.
Systematic Review.
A pentamethoxylated flavone from Glycosmis ovoidea promotes apoptosis through the intrinsic pathway and inhibits migration of MCF-7 breast cancer cells.
Gerardo D Anaya-Eugenio, Peter J Blanco Carcache, +3 authors, A Douglas Kinghorn.
Phytother Res, 2020 Oct 31; 35(3). PMID: 33124130    Free PMC article.
So alike yet so different. Differential expression of the long non-coding RNAs NORAD and HCG11 in breast cancer subtypes.
Carolina Mathias, Gabrielle Araújo Pedroso, +6 authors, Daniela Fiori Gradia.
Genet Mol Biol, 2021 Mar 20; 44(1). PMID: 33739352    Free PMC article.
Moscatilin Suppresses the Breast Cancer Both In Vitro and In Vivo by Inhibiting HDAC3.
Wenjie Su, Lianfu Zeng, Weida Chen.
Dose Response, 2021 Apr 03; 19(1). PMID: 33795998    Free PMC article.
Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine.
Seung E Cha, Maciej Kujawski, +2 authors, John E Shively.
Oncoimmunology, 2021 Apr 03; 10(1). PMID: 33796409    Free PMC article.
Presacral Tumor: Insights From a Decade's Experience of This Rare and Diverse Disease.
Zeyu Li, Min Lu.
Front Oncol, 2021 Apr 03; 11. PMID: 33796466    Free PMC article.
Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer.
Jessica Olson, Patricia Sheean, +5 authors, Melinda Stolley.
Future Sci OA, 2021 Apr 06; 7(4). PMID: 33815828    Free PMC article.
The Exciting New Field of HER2-Low Breast Cancer Treatment.
Daniel Eiger, Elisa Agostinetto, Rita Saúde-Conde, Evandro de Azambuja.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33804398    Free PMC article.
Breast Cancer and the Other Non-Coding RNAs.
Dana Dvorská, Dušan Braný, +2 authors, Zuzana Danková.
Int J Mol Sci, 2021 Apr 04; 22(6). PMID: 33807045    Free PMC article.
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.
Xiuzhi Zhu, Li Chen, +6 authors, Zhonghua Wang.
J Exp Clin Cancer Res, 2021 Apr 10; 40(1). PMID: 33832512    Free PMC article.
Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.
Ruizhong Wang, Brijesh Kumar, +13 authors, Harikrishna Nakshatri.
JCSM Rapid Commun, 2021 Apr 13; 4(1). PMID: 33842876    Free PMC article.
The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.
Qinchao Wu, Baochen Bai, +5 authors, Xianming Chu.
Cardiovasc Drugs Ther, 2021 Apr 14;. PMID: 33847848
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
Maria Alice Franzoi, Daniel Eiger, +11 authors, Evandro de Azambuja.
J Natl Cancer Inst, 2020 Aug 05; 113(4). PMID: 32750143    Free PMC article.
Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1.
Wenfang Luo, Fei Wang, Hewei Luo, Hui Liu.
Exp Ther Med, 2021 Apr 15; 21(6). PMID: 33850519    Free PMC article.
PCAT-1 facilitates breast cancer progression via binding to RACK1 and enhancing oxygen-independent stability of HIF-1α.
Jianlong Wang, Xuyi Chen, +7 authors, Bin Liu.
Mol Ther Nucleic Acids, 2021 Apr 15; 24. PMID: 33850635    Free PMC article.
Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer.
Mengwei Wang, Tianwei Xu, +2 authors, Zhaoxia Wang.
Onco Targets Ther, 2021 Apr 16; 14. PMID: 33854336    Free PMC article.
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Zheqiong Tan, Yaru Zou, +9 authors, Zhongxin Lu.
BMC Cancer, 2021 Apr 17; 21(1). PMID: 33858374    Free PMC article.
The effect of comorbidity on primary care use during breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data.
Rachel L Walsh, Aisha K Lofters, +2 authors, Eva Grunfeld.
CMAJ Open, 2021 Apr 03; 9(2). PMID: 33795223    Free PMC article.
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.
Maria Alice Franzoi, Rita Saúde-Conde, +3 authors, Evandro de Azambuja.
Breast, 2021 Apr 03; 57. PMID: 33799232    Free PMC article.
Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Li Chen, Ping Bai, +5 authors, Jing Wang.
Front Cell Dev Biol, 2021 Apr 17; 9. PMID: 33859986    Free PMC article.
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling.
Yanlin Ren, Dongyin Chen, +4 authors, Jianwei Zhou.
Cell Death Discov, 2021 Apr 21; 7(1). PMID: 33875644    Free PMC article.
Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.
Zicong Gao, Xingxing Han, +7 authors, Fei Zhang.
Cell Death Dis, 2021 Apr 22; 12(5). PMID: 33879771    Free PMC article.
An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors.
Anne Kreklau, Ivonne Nel, +3 authors, Bahriye Aktas.
In Vivo, 2021 Feb 25; 35(2). PMID: 33622896    Free PMC article.
Expression and Prognosis of Sperm-Associated Antigen 1 in Human Breast Cancer.
Shuangyan Lin, Yanbo Lv, +2 authors, Fang Peng.
Onco Targets Ther, 2021 Apr 24; 14. PMID: 33888993    Free PMC article.
An expanded universe of cancer targets.
William C Hahn, Joel S Bader, +21 authors, Cancer Target Discovery and Development Network.
Cell, 2021 Mar 06; 184(5). PMID: 33667368    Free PMC article.
Ribosomal RNA Transcription Regulation in Breast Cancer.
Cecelia M Harold, Amber F Buhagiar, Yan Cheng, Susan J Baserga.
Genes (Basel), 2021 Apr 04; 12(4). PMID: 33805424    Free PMC article.
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.
Rin Ogiya, Naoki Niikura, +19 authors, Hiromitsu Jinno.
Breast Cancer Res Treat, 2020 Aug 21; 184(2). PMID: 32816191
Molecular Classification Based on Prognostic and Cell Cycle-Associated Genes in Patients With Colon Cancer.
Zhiyuan Zhang, Meiling Ji, +4 authors, Jianmin Xu.
Front Oncol, 2021 Apr 27; 11. PMID: 33898311    Free PMC article.
Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase.
Chenyang Xue, Wei Chen, +8 authors, Duo Zheng.
Front Pharmacol, 2021 Apr 30; 12. PMID: 33912035    Free PMC article.
Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies.
Ana Aurora Díaz-Gavela, Lourdes Figueiras-Graillet, +6 authors, Teresa López-Fernández.
Cancers (Basel), 2021 May 01; 13(7). PMID: 33916644    Free PMC article.
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.
Alamelu G Bharadwaj, Ryan W Holloway, Victoria A Miller, David M Waisman.
Cancers (Basel), 2021 May 01; 13(8). PMID: 33921488    Free PMC article.
A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression.
Ting Wang, Jingjing Dong, +5 authors, Wanli Deng.
Front Pharmacol, 2021 May 01; 12. PMID: 33927626    Free PMC article.
High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer.
Li Chen, Xiuzhi Zhu, +3 authors, Zhonghua Wang.
Front Oncol, 2021 May 01; 11. PMID: 33928027    Free PMC article.
E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential.
Yuanqi Liu, Chaojun Duan, Chunfang Zhang.
Front Pharmacol, 2021 May 04; 12. PMID: 33935743    Free PMC article.
Imaging Early-Stage Metastases Using an 18F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant.
Christian A Mason, Lukas M Carter, +7 authors, Jason S Lewis.
Mol Imaging Biol, 2020 Nov 07; 23(3). PMID: 33156495    Free PMC article.
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort.
Thomas Grinda, Natacha Joyon, +24 authors, Magali Lacroix-Triki.
NPJ Breast Cancer, 2021 Apr 18; 7(1). PMID: 33863896    Free PMC article.
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
Xinxing Wang, Bingjian Xue, +3 authors, Dongwei Dou.
Cell Death Dis, 2021 Apr 21; 12(5). PMID: 33875646    Free PMC article.
Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression.
Jing Jin, Yi Li, +3 authors, JingBo Wu.
Cell Commun Signal, 2021 May 08; 19(1). PMID: 33957948    Free PMC article.
CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer.
Xin-le Han, Jun Du, +8 authors, Zheng-Yu Fang.
Biomed Res Int, 2021 May 08; 2021. PMID: 33959656    Free PMC article.
Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo.
Jiang Du, Hong Zhong, Binlin Ma.
Cancer Cell Int, 2021 May 07; 21(1). PMID: 33952250    Free PMC article.
Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
Zhi-Hong Sun, Chuang Chen, +3 authors, Wei-Xing Wang.
Medicine (Baltimore), 2021 May 06; 100(18). PMID: 33951002    Free PMC article.
CircRNAs: role in human diseases and potential use as biomarkers.
Lorena Verduci, Emilio Tarcitano, +2 authors, Giovanni Blandino.
Cell Death Dis, 2021 May 13; 12(5). PMID: 33976116    Free PMC article.
A Qualitative Study of the Experiences of Living With Multiple Myeloma.
Matthew R LeBlanc, Thomas W LeBlanc, +3 authors, Sophia K Smith.
Oncol Nurs Forum, 2021 Feb 19; 48(2). PMID: 33600390    Free PMC article.
MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer.
Qiang Feng, Yanbin Ren, +6 authors, Xiaoying Hou.
J Breast Cancer, 2021 Apr 06; 24(2). PMID: 33818020    Free PMC article.
The Tetramethylpyrazine Derivative Statmp-151: A Novel Small Molecule Stat3 Inhibitor With Promising Activity Against Breast Cancer.
Chen Fan, Yijie Wang, +13 authors, Jian Gu.
Front Pharmacol, 2021 May 11; 12. PMID: 33967793    Free PMC article.
CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
Yanzhu Chen, Zhishang Meng, Lin Zhang, Feng Liu.
Front Immunol, 2021 May 11; 12. PMID: 33968066    Free PMC article.
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Elizabeth M Salvo, Abril Oliva Ramirez, +4 authors, Imtiaz A Samjoo.
Breast, 2021 Mar 08; 57. PMID: 33677313    Free PMC article.
FOXO3a inhibits the EMT and metastasis of breast cancer by regulating TWIST-1 mediated miR-10b/CADM2 axis.
Long Jin, Jun Zhang, +2 authors, Yu-Liang Pan.
Transl Oncol, 2021 Apr 22; 14(7). PMID: 33882368    Free PMC article.
Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.
Apolonia Novillo, Ana Fernández-Santander, +4 authors, Pablo Gómez-Del Arco.
Front Oncol, 2021 May 14; 11. PMID: 33981601    Free PMC article.
Single cell RNA sequencing for breast cancer: present and future.
Lili Ren, Junyi Li, +8 authors, Jing Tang.
Cell Death Discov, 2021 May 16; 7(1). PMID: 33990550    Free PMC article.
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Lara Malik Noureddine, Olivier Trédan, +3 authors, Coralie Poulard.
Int J Mol Sci, 2021 May 01; 22(9). PMID: 33923160    Free PMC article.
Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer.
Hanyi Fang, Alessandra Cavaliere, +2 authors, Bernadette Marquez-Nostra.
Front Pharmacol, 2021 May 15; 12. PMID: 33986665    Free PMC article.
Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway.
Ting Yang, Yi-Xin Jiang, +7 authors, Xin Luan.
Front Pharmacol, 2021 May 18; 12. PMID: 33995111    Free PMC article.
Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study.
Yi Li, Yixuan Qiu, +6 authors, Rui Ge.
Front Oncol, 2021 May 18; 11. PMID: 33996589    Free PMC article.
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance.
Meng-Ge Du, Zhi-Qiang Peng, +9 authors, Ping Xie.
Front Cell Dev Biol, 2021 May 18; 9. PMID: 33996822    Free PMC article.
Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study.
Meng Jiang, Di Zhang, +7 authors, Christoph F Dietrich.
Eur Radiol, 2020 Nov 24; 31(6). PMID: 33226454
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Fei Lu, Yu Hou, +6 authors, Wenhui Li.
Technol Cancer Res Treat, 2021 May 13; 20. PMID: 33977814    Free PMC article.
miRNA-Based Therapeutics in Breast Cancer: A Systematic Review.
Anna Maria Grimaldi, Marco Salvatore, Mariarosaria Incoronato.
Front Oncol, 2021 May 25; 11. PMID: 34026646    Free PMC article.
Systematic Review.
The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors.
Zhizhu Zhang, Ann Richmond.
Front Mol Biosci, 2021 May 25; 8. PMID: 34026830    Free PMC article.
OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Jianing Tang, Zeyu Wu, +2 authors, Gaosong Wu.
Cell Death Dis, 2021 May 27; 12(6). PMID: 34035221    Free PMC article.
Prognostic value of response evaluation based on breast MRI after neoadjuvant treatment: a retrospective cohort study.
Almir G V Bitencourt, Barbara S Pires, +11 authors, Rubens Chojniak.
Eur Radiol, 2021 May 27;. PMID: 34036420
Systemic Immunotherapy with Micellar Resiquimod-Polymer Conjugates Triggers a Robust Antitumor Response in a Breast Cancer Model.
Hamilton Kakwere, Hua Zhang, +11 authors, Katherine W Ferrara.
Adv Healthc Mater, 2021 Mar 02; 10(10). PMID: 33646600    Free PMC article.
Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
Siyu Ma, Donald S Shepard, +2 authors, Cindy Parks Thomas.
PLoS One, 2021 May 19; 16(5). PMID: 34003865    Free PMC article.
Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT.
Yulu Zhou, Jingjing Yang, +5 authors, Jichun Zhou.
Front Pharmacol, 2021 May 28; 12. PMID: 34040532    Free PMC article.
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Abel Tesfaye Anshabo, Robert Milne, Shudong Wang, Hugo Albrecht.
Front Oncol, 2021 May 28; 11. PMID: 34041038    Free PMC article.
The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer.
Zhenbo Tu, Johannes Schmoellerl, +4 authors, Antoine E Karnoub.
NPJ Breast Cancer, 2021 Jun 02; 7(1). PMID: 34059683    Free PMC article.
Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer.
Samitha Andrahennadi, Amer Sami, +2 authors, Shahid Ahmed.
Curr Oncol, 2021 Jun 03; 28(3). PMID: 34064867    Free PMC article.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Anna Maria Wirsing, Inger-Heidi Bjerkli, +6 authors, Elin Hadler-Olsen.
Cancers (Basel), 2021 Jun 03; 13(10). PMID: 34069237    Free PMC article.
FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties.
Mario Díaz, Fernando Lobo, +9 authors, Fernando Lahoz.
Int J Mol Sci, 2021 Jun 03; 22(10). PMID: 34069498    Free PMC article.
Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma.
Shouyue Zhang, Jin Zhang, +5 authors, Bo Liu.
Acta Pharm Sin B, 2021 Jun 08; 11(5). PMID: 34094830    Free PMC article.
Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells.
Zheng Li, Xuekun Fu, +4 authors, Chao Liang.
Front Cell Dev Biol, 2021 Jun 08; 9. PMID: 34095130    Free PMC article.
miR-224-5p Carried by Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Regulates Autophagy in Breast Cancer Cells via HOXA5.
Yichao Wang, Pan Wang, +4 authors, Zhaoyun Li.
Front Cell Dev Biol, 2021 Jun 08; 9. PMID: 34095151    Free PMC article.
Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
Fabiola N Velazquez, Leiqing Zhang, +4 authors, Ashley J Snider.
PLoS One, 2021 May 28; 16(5). PMID: 34043703    Free PMC article.
Hyperinsulinemia in Obesity, Inflammation, and Cancer.
Anni M Y Zhang, Elizabeth A Wellberg, Janel L Kopp, James D Johnson.
Diabetes Metab J, 2021 Mar 30; 45(3). PMID: 33775061    Free PMC article.
Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition.
Jingyu Peng, Ming Yang, +6 authors, Wei Wei.
Front Oncol, 2021 Jun 11; 11. PMID: 34109118    Free PMC article.
Chemotherapy Treatment Considerations in Metastatic Breast Cancer.
Kirollos Hanna, Kelley Mayden.
J Adv Pract Oncol, 2021 Jun 12; 12(Suppl 2). PMID: 34113474    Free PMC article.
The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer.
Kirollos Hanna, Kelley Mayden.
J Adv Pract Oncol, 2021 Jun 12; 12(Suppl 2). PMID: 34113475    Free PMC article.
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis.
You Qin, Fei Peng, +4 authors, Yu Hu.
Cancer Cell Int, 2021 Jun 14; 21(1). PMID: 34118931    Free PMC article.
Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer.
Fei Wang, Chong Yuan, +2 authors, Yan-Fang Yang.
Front Oncol, 2021 Jun 15; 11. PMID: 34123826    Free PMC article.
Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Paulina Karin Grillo, Balázs Győrffy, Martin Götte.
J Cancer Res Clin Oncol, 2021 Mar 21; 147(7). PMID: 33742285    Free PMC article.
The past, present, and future of breast cancer models for nanomedicine development.
Paz Boix-Montesinos, Paula M Soriano-Teruel, +2 authors, María J Vicent.
Adv Drug Deliv Rev, 2021 Apr 03; 173. PMID: 33798642    Free PMC article.
Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety.
Ji Taek Hong.
Ther Clin Risk Manag, 2021 Jun 18; 17. PMID: 34135588    Free PMC article.
Immediate breast reconstruction using latissimus dorsi muscular flap: A retrospective study of Chinese patients with breast cancer.
Qiuming Liu, Weifeng Li, +3 authors, Yali Cao.
Medicine (Baltimore), 2021 Jun 16; 100(24). PMID: 34128848    Free PMC article.
High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.
Chuanhui Xu, Jinhui Yu, +4 authors, Gang Wu.
Am J Transl Res, 2021 Jun 22; 13(5). PMID: 34150024    Free PMC article.
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer.
Wenbai Huang, Yijiao Chen, +8 authors, Jianmin Xu.
J Cancer Res Clin Oncol, 2021 Jun 23;. PMID: 34156520
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
Maya Dadiani, Daniela Necula, +14 authors, Adit Ben-Baruch.
Cancer Immunol Immunother, 2020 Mar 22; 69(7). PMID: 32198536
Retrospective analysis of the effect of breast surgery on body posture in patients with early-stage breast cancer after cancer treatment (VENUS study) (Breast cancer and body posture)
Özgür Tanrıverdi, Ahmet Ozan Çetin, Ali Alkan.
Turk J Med Sci, 2020 Jul 29; 51(2). PMID: 32718123    Free PMC article.
Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers.
Min-Hua Lai, Chi-Hsun Liao, +5 authors, Chen-Si Lin.
Cancer Control, 2021 Apr 24; 28. PMID: 33887987    Free PMC article.
Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application.
Yubo Shi, Qingyun Huang, +4 authors, Lixia Xiong.
Life (Basel), 2021 Jun 03; 11(6). PMID: 34073224    Free PMC article.
The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients.
C van Dooijeweert, I O Baas, +3 authors, E van der Wall.
Breast Cancer Res Treat, 2021 Feb 01; 187(2). PMID: 33517555    Free PMC article.
TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.
María Paz Saldías, Diego Maureira, +6 authors, Oscar Cerda.
Front Oncol, 2021 Jun 29; 11. PMID: 34178620    Free PMC article.
Systematic Review.
The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway.
Kan Ni, Zhiqi Huang, +4 authors, Changjiang Gu.
Front Oncol, 2021 Jun 29; 11. PMID: 34178640    Free PMC article.
Neoantigens elicit T cell responses in breast cancer.
Takafumi Morisaki, Makoto Kubo, +10 authors, Masafumi Nakamura.
Sci Rep, 2021 Jul 02; 11(1). PMID: 34193879    Free PMC article.
A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.
Zhimin Ye, Shengmei Zou, +2 authors, Yongbin Hu.
Front Cell Dev Biol, 2021 Jul 02; 9. PMID: 34195202    Free PMC article.
A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data.
Regan Odongo, Asuman Demiroglu-Zergeroglu, Tunahan Çakır.
BMC Complement Med Ther, 2021 Jul 02; 21(1). PMID: 34193143    Free PMC article.
Sex Hormones Related Ocular Dryness in Breast Cancer Women.
Antonella Grasso, Antonio Di Zazzo, +10 authors, Vittorio Altomare.
J Clin Med, 2021 Jul 03; 10(12). PMID: 34198684    Free PMC article.
Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols-Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties.
Konrad Chojnacki, Patrycja Wińska, +6 authors, Paweł Borowiecki.
Int J Mol Sci, 2021 Jul 03; 22(12). PMID: 34200807    Free PMC article.
Polysaccharides with Antitumor Effect in Breast Cancer: A Systematic Review of Non-Clinical Studies.
Claudia Rita Corso, Natalia Mulinari Turin de Oliveira, +5 authors, Daniele Maria-Ferreira.
Nutrients, 2021 Jul 03; 13(6). PMID: 34200897    Free PMC article.
Systematic Review.
Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer.
Fatemah Bahman, Valeria Pittalà, Mohamed Haider, Khaled Greish.
J Pers Med, 2021 Jul 03; 11(6). PMID: 34204015    Free PMC article.
Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro.
Antonio Fernando Leis-Filho, Patrícia de Faria Lainetti, +2 authors, Renée Laufer-Amorim.
Pharmaceutics, 2021 Jul 03; 13(6). PMID: 34204236    Free PMC article.
The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment.
Nicolas J Niklaus, Igor Tokarchuk, +3 authors, Mario P Tschan.
Cells, 2021 Jul 03; 10(6). PMID: 34207792    Free PMC article.
4,6'-Anhydrooxysporidinone from Fusarium lateritium SSF2 Induces Autophagic and Apoptosis Cell Death in MCF-7 Breast Cancer Cells.
Dahae Lee, Sanghee Shim, Kisung Kang.
Biomolecules, 2021 Jul 03; 11(6). PMID: 34208033    Free PMC article.
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer.
Jonathan M Ghergurovich, Jessica D Lang, +16 authors, Joshua D Rabinowitz.
Med (N Y), 2021 Jul 06; 2(6). PMID: 34223403    Free PMC article.
The regulation of RNA metabolism in hormone signaling and breast cancer.
Xiaofei Wang, Da Yang.
Mol Cell Endocrinol, 2021 Mar 13; 529. PMID: 33711334    Free PMC article.
Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer.
Juanjuan Li, Bradley M Downs, +14 authors, Saraswati Sukumar.
NPJ Breast Cancer, 2021 Jul 09; 7(1). PMID: 34234148    Free PMC article.
Fatty Acid-Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway.
Zimeng Wu, Ji-Hak Jeong, +6 authors, Jie Lu.
Onco Targets Ther, 2021 Jul 09; 14. PMID: 34234461    Free PMC article.
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response.
Femke A I Ehlers, Nicky A Beelen, +5 authors, Lotte Wieten.
Cancers (Basel), 2021 Jul 03; 13(13). PMID: 34203549    Free PMC article.
The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer.
Karan Ulhaka, Kanyanatt Kanokwiroon, +3 authors, Pasarat Khongkow.
Int J Mol Sci, 2021 Jul 03; 22(13). PMID: 34206484    Free PMC article.
Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer.
Yoshihisa Tokumaru, Masanori Oshi, +9 authors, Kazuaki Takabe.
Am J Cancer Res, 2021 Jul 13; 11(6). PMID: 34249465    Free PMC article.
Effects of Surgery on Prognosis of Young Women With Operable Breast Cancer in Different Marital Statuses: A Population-Based Cohort Study.
Junsheng Zhang, Ciqiu Yang, +9 authors, Kun Wang.
Front Oncol, 2021 Jul 13; 11. PMID: 34249703    Free PMC article.
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients.
Shuai Li, Jiayi Wu, +6 authors, Kunwei Shen.
BMC Cancer, 2021 Jul 15; 21(1). PMID: 34256710    Free PMC article.
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth.
Hirotaka Kanzaki, Avradip Chatterjee, +7 authors, Ramachandran Murali.
Breast Cancer (Dove Med Press), 2021 Jul 16; 13. PMID: 34262338    Free PMC article.
Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence.
Yihang Qi, Lin Zhang, +4 authors, Jing Wang.
Front Pharmacol, 2021 Jul 17; 12. PMID: 34267656    Free PMC article.
Quercetin Synergistically Enhances the Anticancer Efficacy of Docetaxel through Induction of Apoptosis and Modulation of PI3K/AKT, MAPK/ERK, and JAK/STAT3 Signaling Pathways in MDA-MB-231 Breast Cancer Cell Line.
Amir Safi, Esfandiar Heidarian, Reza Ahmadi.
Int J Mol Cell Med, 2021 Jul 17; 10(1). PMID: 34268250    Free PMC article.
Identification and Validation of Immune-Related Methylation Clusters for Predicting Immune Activity and Prognosis in Breast Cancer.
Anli Yang, Ying Zhou, +8 authors, Weikai Xiao.
Front Immunol, 2021 Jul 20; 12. PMID: 34276701    Free PMC article.
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.
Jun Cao, Mengdi Zhang, +3 authors, Fangfang Zhou.
Front Oncol, 2021 Jul 20; 11. PMID: 34277408    Free PMC article.
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Xinhui Li, Jian Zhou, +11 authors, Jing Tang.
Front Cell Dev Biol, 2021 Jul 20; 9. PMID: 34277633    Free PMC article.
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis.
Mingzhi Zhu, Yanyan Wang, +2 authors, Xinguang Qiu.
Cancer Cell Int, 2021 Jul 21; 21(1). PMID: 34281530    Free PMC article.
The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.
Zhen Li, Ji Zhang, +12 authors, Ceshi Chen.
PLoS One, 2021 Jul 10; 16(7). PMID: 34242313    Free PMC article.
Key Role of MCUR1 in Malignant Progression of Breast Cancer.
Peipei Gao, Ting Peng, +7 authors, Wencheng Ding.
Onco Targets Ther, 2021 Jul 22; 14. PMID: 34285508    Free PMC article.
A new immunochemical strategy for triple-negative breast cancer therapy.
Chih-Wei Lin, Tianqing Zheng, +3 authors, Richard A Lerner.
Sci Rep, 2021 Jul 23; 11(1). PMID: 34290315    Free PMC article.
Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.
Sharda P Singh, Jihyun Lee, +9 authors, Sanjay Awasthi.
Cancers (Basel), 2021 Jul 21; 13(13). PMID: 34283045    Free PMC article.
Organ-Specific, Fibroblast-Derived Matrix as a Tool for Studying Breast Cancer Metastasis.
Adina R D Jensen, Edward R Horton, +5 authors, Janine T Erler.
Cancers (Basel), 2021 Jul 21; 13(13). PMID: 34283050    Free PMC article.
Targeted Sequencing of Taiwanese Breast Cancer with Risk Stratification by the Concurrent Genes Signature: A Feasibility Study.
Ching-Shui Huang, Chih-Yi Liu, +4 authors, Chi-Cheng Huang.
J Pers Med, 2021 Jul 03; 11(7). PMID: 34203389    Free PMC article.
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Heng Liu, Gangyue Wang.
Exp Ther Med, 2021 Jul 27; 22(3). PMID: 34306209    Free PMC article.
Perspectives on interstitial photodynamic therapy for malignant tumors.
Katarzyna Komolibus, Carl Fisher, +3 authors, Stefan Andersson-Engels.
J Biomed Opt, 2021 Jul 25; 26(7). PMID: 34302323    Free PMC article.
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Nair Hariprasad Haritha, Akbar Nawab, +16 authors, Ruby John Anto.
Front Oncol, 2021 Aug 03; 11. PMID: 34336653    Free PMC article.
Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study.
Lili Zhang, Xiaohong Wu, +16 authors, Jifeng Feng.
Front Oncol, 2021 Aug 03; 11. PMID: 34336688    Free PMC article.
β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells.
Fan Zhang, Pan Li, +6 authors, Hao Liu.
Oncogene, 2021 Aug 05;. PMID: 34345015
Optimal solution of the fractional order breast cancer competition model.
H Hassani, J A Tenreiro Machado, +2 authors, S Mehrabi.
Sci Rep, 2021 Aug 04; 11(1). PMID: 34341390    Free PMC article.
PCDHB17P/miR-145-3p/MELK/NF-κB Feedback Loop Promotes Metastasis and Angiogenesis of Breast Cancer.
Li Zhu, Yan-Jun Zhang, +6 authors, Jian-Dong Wang.
Front Oncol, 2021 Aug 06; 11. PMID: 34350110    Free PMC article.
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Jessica Castrillon Lal, Madeline G Townsend, +7 authors, Jennifer L Guerriero.
Breast Cancer Res, 2021 Aug 07; 23(1). PMID: 34353349    Free PMC article.
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment.
Dang Tan Nguyen, Thi Khanh Le, +8 authors, Palma Rocchi.
Biomedicines, 2021 Aug 07; 9(7). PMID: 34356858    Free PMC article.
Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer.
Diana P Saraiva, Sofia Azeredo-Lopes, +9 authors, M Guadalupe Cabral.
Cancers (Basel), 2021 Aug 08; 13(15). PMID: 34359741    Free PMC article.
Cell Membrane-Coated Halloysite Nanotubes for Target-Specific Nanocarrier for Cancer Phototherapy.
Cuiying Tan, Jingqi Zheng, Yue Feng, Mingxian Liu.
Molecules, 2021 Aug 08; 26(15). PMID: 34361636    Free PMC article.
Spatially offset Raman spectroscopy for biomedical applications.
Fay Nicolson, Moritz F Kircher, Nick Stone, Pavel Matousek.
Chem Soc Rev, 2020 Nov 11; 50(1). PMID: 33169761    Free PMC article.
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.
Mohammad Sultan, Jacob T Nearing, +10 authors, Paola Marcato.
Mol Oncol, 2021 May 02; 15(8). PMID: 33932086    Free PMC article.
GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer.
Yan Yang, Xin He, +9 authors, Jing-Wei Zhang.
Front Oncol, 2021 Aug 10; 11. PMID: 34367945    Free PMC article.
Genome-wide crosstalk between steroid receptors in breast and prostate cancers.
Ville Paakinaho, Jorma J Palvimo.
Endocr Relat Cancer, 2021 Jun 18; 28(9). PMID: 34137734    Free PMC article.
Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer.
Tzu-Pei Su, Jen-Seng Huang, +4 authors, Sheng-Chieh Chan.
BMC Cancer, 2021 Aug 12; 21(1). PMID: 34376155    Free PMC article.
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature.
Michael May, Alexander G Raufi, +6 authors, Gulam A Manji.
Oncologist, 2021 Apr 26; 26(8). PMID: 33896096    Free PMC article.
A Comprehensive Review on the Applications of Exosomes and Liposomes in Regenerative Medicine and Tissue Engineering.
Mojtaba Shafiei, Mohamed Nainar Mohamed Ansari, Saiful Izwan Abd Razak, Muhammad Umar Aslam Khan.
Polymers (Basel), 2021 Aug 11; 13(15). PMID: 34372132    Free PMC article.
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway.
Lingyun Qiu, Yan Ma, +5 authors, Jianming Tang.
J Transl Med, 2021 Aug 12; 19(1). PMID: 34376200    Free PMC article.
Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
Fariza Juliana Nordin, Lishantini Pearanpan, +4 authors, Nor Fadilah Rajab.
PLoS One, 2021 Aug 12; 16(8). PMID: 34379689    Free PMC article.
Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer.
Erica L Mayer.
JACC CardioOncol, 2020 Jun 16; 2(2). PMID: 34396228    Free PMC article.
Efficacy of acceptance and commitment therapy (ACT) on depression, pain acceptance, and psychological flexibility in married women with breast cancer: a pre- and post-test clinical trial.
Vajiheh Ghorbani, Zahra Zanjani, Abdollah Omidi, Mostafa Sarvizadeh.
Trends Psychiatry Psychother, 2021 Aug 16; 43(2). PMID: 34392667    Free PMC article.
Gene expression profile analysis of gallic acid-induced cell death process.
Ho Man Tang, Peter Chi Keung Cheung.
Sci Rep, 2021 Aug 20; 11(1). PMID: 34408198    Free PMC article.
Tumor Targeting by Conditioned Medium Derived From Human Amniotic Membrane: New Insight in Breast Cancer Therapy.
Ameneh Jafari, Mostafa Rezaei-Tavirani, Hassan Niknejad, Hakimeh Zali.
Technol Cancer Res Treat, 2021 Aug 18; 20. PMID: 34402329    Free PMC article.
Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation.
Ziyu Liu, Leilei Huang, +5 authors, Xin Hu.
Drug Des Devel Ther, 2021 Aug 20; 15. PMID: 34408399    Free PMC article.
The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.
Jamie J Bernard, Elizabeth A Wellberg.
Am J Pathol, 2021 Feb 28; 191(8). PMID: 33639102    Free PMC article.
Intermammary breast cancer; the first reported case.
Abdulwahid M Salih, Zhair D Hammood, +3 authors, Bakhan S Ali.
Int J Surg Case Rep, 2021 Aug 17; 86. PMID: 34399237    Free PMC article.
Development and validation of a prognostic nomogram for early HER2-positive and lymph node-negative breast cancer.
Qiyun Shi, Ju Wang, +5 authors, Jun Jiang.
Gland Surg, 2021 Aug 24; 10(7). PMID: 34422596    Free PMC article.
Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine in Patients With Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Retrospective Study.
Yizhao Xie, Yi Li, +6 authors, Biyun Wang.
Front Oncol, 2021 Aug 24; 11. PMID: 34422652    Free PMC article.
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Xia Yang, Xin Weng, +7 authors, Xia Liu.
Aging (Albany NY), 2021 Aug 04; 13(15). PMID: 34341184    Free PMC article.
Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer.
Chunli Li, Jiandong Yin.
Diagnostics (Basel), 2021 Aug 28; 11(8). PMID: 34441425    Free PMC article.
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
Yanjun Zhou, Jonas S Heitmann, +9 authors, Clemens Hinterleitner.
Cancer Immunol Immunother, 2021 Feb 05; 70(9). PMID: 33538861    Free PMC article.
Phylogenetic analysis of combined lobular and ductal carcinoma of the breast.
Hiroko Kobayashi, Tokiko Nakai, +2 authors, Shinobu Masuda.
Mol Med Rep, 2021 Aug 17; 24(4). PMID: 34396426    Free PMC article.
Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study.
Jing Wang, Xiaoyu Wang, +7 authors, Hongzhong Li.
Front Oncol, 2021 Aug 31; 11. PMID: 34458132    Free PMC article.